Comments closedI miss my life. And the future is unknown. I don’t know if I’m gonna get better or worse stay the same. I don’t know what I’m dealing with.
Tag: long COVID
Common diabetes drug lowers SARS-CoV-2 levels, clinical trial finds
Today, researchers from the University of Minnesota published evidence that the common diabetes drug metformin decreases the amount of SARS-CoV-2 in the body and helps reduce the risk of rebound symptoms if given early in the course of non-severe illness.
The study, published in Clinical Infectious Diseases, suggests metformin may also help prevent long COVID.
The researchers tested metformin against a placebo in 999 adults infected with COVID-19. More than 50% of the study enrollees were vaccinated, and treatment took place when the Omicron variant was the most dominant strain in the United States.
Comments closedAbout 2m people have long Covid in England and Scotland, figures show
About 2 million people in England and Scotland say they are experiencing long Covid, figures reveal, with many reporting their symptoms have lasted two years or longer.
The findings were released by the Office for National Statistics (ONS) and cover the period from November 2023 to March 2024, revealing of those who reported having long Covid, about 1.5 million people – about three-quarters– felt their day-to-day activities were affected, while 381,000 people – about a fifth – said their ability to undertake such activities had been “limited a lot”.
Comments closedRadio | COVID infections are causing drops in IQ and years of brain aging, studies suggest
When COVID-19 first reared its head back in 2019, it brought with it a slew of strange symptoms beyond just respiratory problems. One of the most puzzling symptoms in those early days was something called “brain fog” — cognitive issues like confusion, forgetfulness, and trouble focusing.
And while other symptoms have changed as the virus mutated, brain fog is still a common complaint of COVID sufferers not only during the initial illness, but extending for months or even years afterwards. Several recent studies have been trying to understand exactly what this virus is doing to our brains — and how to stop it.
Comments closedThree studies spotlight long-term burden of COVID in US adults
Three new studies shed new light on long COVID in the United States, with one finding that two thirds of severely ill patients reported persistent impairments for up to 1 year, another showing that US veterans were at three times the risk of preventable hospitalization in the month after infection, and the last revealing that one third of COVID-19 survivors had lingering symptoms at one time.
Comments closedBernie Sanders calls for $1 billion for long-COVID moonshot
Comments closedCongress must act now to ensure a treatment is found for this terrible disease that affects millions of Americans and their families. Far too many patients with Long COVID have struggled to get their symptoms taken seriously.
More awareness and investment needed to support people with long COVID: SFU report
Comments closedIt’s an invisible and new condition. Many people don’t believe that long COVID is real or exists. And unfortunately, that permeates through the healthcare system. Even outside of the medical system, there is a broader societal awareness that is lacking.
Cost of private Covid jabs risks widening health inequalities, experts warn
Experts and patient groups have warned that the high cost of private Covid vaccinations could exacerbate health inequalities and leave those more at risk from the virus without a vital line of defence.
Both high street chain Boots and pharmacies that partner with the company Pharmadoctor are now offering Covid jabs to those not eligible for a free vaccination through the NHS, with the former charging almost £100 for the Pfizer/BioNTech jab.
While Pharmadoctor says each pharmacy sets its own prices, it suggests the Pfizer/BioNTech jab will set customers back £75-£85, while the latest Novavax jab will cost about £45-£55.
Comments closedNew Data: Long COVID Cases Surge
Experts worry a recent rise in long COVID cases — fueled by a spike in winter holiday infections and a decline in masking and other measures — could continue into this year.
A sudden rise in long COVID in January has persisted into a second month. About 17.6% of those surveyed by the Census Bureau in January said they have experienced long COVID. The number for February was 17.4.
Compare these new numbers to October 2023 and earlier, when long COVID numbers hovered between 14% and 15% of the US adult population as far back as June 2022.
Comments closedAlmost one-in-five suffering from long COVID
A study of more than 11,000 Australians who tested positive to COVID-19 in 2022 has revealed almost one-in-five were still experiencing ongoing symptoms three months after their initial diagnosis, according to new research from The Australian National University (ANU).
The study was conducted in Western Australia (WA), with participants drawn from the almost 71,000 adults who tested positive to COVID-19 in WA between 16 July 2022 and 3 August 2022.
Lead researcher, Dr Mulu Woldegiorgis, said the results show the risk of developing long COVID from the Omicron variant is higher than previously thought.
Comments closed